NCT02433392View on ClinicalTrials.gov

Study of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme.

PHASE1TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Glioma
Interventions
PROCEDURE

CM-BC2

CM-BC2 is a drug-eluting bead, a drug-device combination

Trial Locations (1)

B15 2TH

Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham

Sponsors
All Listed Sponsors
collaborator

University of Birmingham

OTHER

lead

Boston Scientific Corporation

INDUSTRY